Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Cliff Donald Blessing sold 2,000 shares of Addus HomeCare stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $124.18, for a total transaction of $248,360.00. Following the transaction, the executive vice president directly owned 10,183 shares in the company, valued at approximately $1,264,524.94. The trade was a 16.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Addus HomeCare Stock Performance
Shares of NASDAQ:ADUS opened at $125.49 on Thursday. The company has a market capitalization of $2.34 billion, a price-to-earnings ratio of 20.91, a price-to-earnings-growth ratio of 1.66 and a beta of 0.75. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $131.59. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.02. The firm has a 50 day moving average of $118.19 and a 200 day moving average of $107.10.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. Addus HomeCare’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.56 earnings per share. On average, sell-side analysts predict that Addus HomeCare Corporation will post 6.41 earnings per share for the current fiscal year.
Trending Headlines about Addus HomeCare
These are some of the ADUS headlines that stood out recently:
- Positive Sentiment: TD Cowen raised its price target to $145 and reiterated a Buy rating; Wall Street Zen also upgraded the stock to Strong Buy. The company’s latest reported quarterly EPS of $1.83 topped the $1.79 consensus, while revenue grew 7% year over year, though it narrowly missed estimates.
- Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
- Negative Sentiment: Several executives sold shares on Nov. 6, and CEO R. Allison sold 98,958 shares on Nov. 9 for about $12.2 million, reducing his stake by 35.08%. Five executive vice presidents also sold a combined 32,697 shares. The volume of insider selling may weigh on investor sentiment, though sales alone do not establish a negative view of the company. CEO sale filing Article: EVP share sale
Wall Street Analysts Forecast Growth
ADUS has been the subject of a number of analyst reports. Royal Bank Of Canada upped their price objective on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Raymond James Financial set a $137.00 target price on Addus HomeCare in a research note on Monday, September 28th. Citigroup lowered Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research note on Monday, September 14th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Finally, Truist Financial increased their price target on shares of Addus HomeCare from $135.00 to $148.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $134.70.
View Our Latest Stock Report on Addus HomeCare
Institutional Investors Weigh In On Addus HomeCare
Several institutional investors have recently bought and sold shares of ADUS. Hantz Financial Services Inc. grew its holdings in Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock worth $69,000 after purchasing an additional 109 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Addus HomeCare by 16.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after purchasing an additional 111 shares during the last quarter. Assenagon Asset Management S.A. lifted its holdings in shares of Addus HomeCare by 2.0% during the 2nd quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company’s stock valued at $593,000 after purchasing an additional 114 shares during the last quarter. Net Worth Advisory Group lifted its holdings in shares of Addus HomeCare by 4.1% during the 3rd quarter. Net Worth Advisory Group now owns 3,419 shares of the company’s stock valued at $382,000 after purchasing an additional 136 shares during the last quarter. Finally, Hohimer Wealth Management LLC lifted its holdings in shares of Addus HomeCare by 5.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 2,809 shares of the company’s stock valued at $311,000 after purchasing an additional 143 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
About Addus HomeCare
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
